Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
Condition: Graft Versus Host Disease in Eye Interventions: Drug: Cyclosporine; Drug: tacrolimus Sponsor: Peking University Third Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials